Trial intelligence / Profile preview

Methoxyflurane vs Placebo for Pain in Oral and Dental Emergencies

NCT06495372Phase 3Completed

Sponsor
Centre Hospitalier Universitaire de Brest
Start
Oct 2024
Primary completion
Oct 2025
Modality
Allosteric Modulators
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of methoxyflurane in odontalgia (2 arms), sponsored by Centre Hospitalier Universitaire de Brest. Primary endpoint: Pain assessed by a numerical rating scale at 15 minutes. Started Oct 2024; status: completed.

02

Drugs

methoxyflurane
03

Conditions

odontalgia

Beyond the preview

Go deeper on NCT06495372.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06495372.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call